NASDAQ:ATRA Investor Alert: Investigation over Potential Wrongdoing at Atara Biotherapeutics, Inc.
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Atara Biotherapeutics, Inc.
View full press release